Recent News

• 02.10.2026 - Harmony Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
• 01.12.2026 - Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation
• 01.07.2026 - Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
• 12.08.2025 - Harmony Biosciences Presents Clinically Meaningful Open-Label Extension Study Effectiveness Data for EPX-100 in Dravet Syndrome

Recent Filings

• 02.05.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.28.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.26.2026 - 144 Report of proposed sale of securities
• 01.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.20.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.15.2026 - 144 Report of proposed sale of securities